About RegenMed
RegenMed is a Healthcare company based in Greenwich (United States) founded in 2014 by Michael Tierney and J William Futrell. It operates as a healthcare data analytics company that enables clinical and financial value creation for clinicians. RegenMed has raised $290 thousand across 1 funding round. Its chief executive is Michael Tierney. RegenMed offers products and services including inCytesâ„¢, Benchmarcâ„¢, and Circles. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is RegenMed, Inc. Its competitors include Fauna Bio, Predxbio, BeaconCure, Humaneva Group and Private Health Management and 1 more; 4 of its 6 listed competitors have raised funding.
Company details
RegenMed was founded in 2014 in Greenwich, United States, as a healthcare technology firm specializing in translational regenerative medicine. A platform has been developed for collecting and analyzing real-world evidence to support medical research. Operations serve a global client base in the healthcare data sector, with services focused on clinical and financial outcomes for clinicians. Partnerships with leading healthcare organizations have been established, alongside backing from investors.
- Headquarters Greenwich, United States
- Founders Michael Tierney, J William Futrell
- SectorsHealthcare
- Website rgnmed.com
- Social LinkedIn X Facebook YouTube
- Legal Name Regenmed, Inc.
- Total Equity Funding$290K (USD)
in 1 rounds
- Latest Funding Round$290K (USD), Seed
Feb 2025
Products & Services of RegenMed
RegenMed offers a comprehensive portfolio of products and services, including inCytes™, Benchmarc™, and Circles.
Platform for healthcare data analysis and validation processes
System for medical research protocols and outcomes tracking
Network for physician-designed studies and data monetization
Apps and channels of RegenMed
its YouTube channel RegenMed, Inc. has 30 subscribers and 23 videos.
Videos from RegenMed
The most watched videos on RegenMed's YouTube channel, RegenMed, Inc. (30 subscribers). Click a video to play it here.
More on RegenMed, Inc..
Funding Insights of RegenMed
RegenMed has successfully raised a total of $290K through 1 strategic funding round. The most recent funding activity was a Seed round of $290 thousand completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $290,000
- Total Rounds 1
- Last Round Seed — $290,000
- First Round $290,000
(Feb 2025)
All 1 funding rounds of RegenMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $290,000 | Seed | – | – | – |
People of RegenMed
6 people are tracked at RegenMed (4 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Michael Tierney | Co-Founder & CEO | Leadership |
J William Futrell | Co-Founder | Leadership |
M. D. | Director, Center For Regenerative Orthopedic Med | Leadership |
Dan A. Grande | Director Of Operations/ Orthopaedic Res. At Feinstein Institute | Leadership |
Alexandra Lovkina | Content Manager | Team |
Victoria Zaharova | Quality Assurance Manager | Team |
Complete people profiles for RegenMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RegenMed
2 dated milestones of RegenMed across 11 years, from founding to its latest funding, stage changes and deals.
- Founded RegenMed is founded.
- Funding First funding round of $290K.
Competitors of RegenMed
RegenMed has 6 listed competitors in our database, 4 of them funded. They include Fauna Bio, Predxbio, BeaconCure, Humaneva Group and Private Health Management, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| faunabio.com | 2018 | Berkeley, United States | $13.1M | 19 | Animal genomics is applied to healthcare advancements by Fauna Bio. | |
| predxbio.com | 2017 | Pittsburgh, United States | $1.4M | – | AI-based drug discovery and clinical services are provided for biopharma. | |
| beaconcure.com | 2016 | Tel Aviv, Israel | $40.92M | – | Data analytics and validation software for regulatory submission in the healthcare sector | |
| humaneva.com | 2014 | Raleigh, United States | $50M | – | Provider of clinical research data services for oncology & other therapeutic areas | |
| privatehealth.com | 2007 | Los Angeles, United States | – | – | Provides personalized healthcare guidance for complex diseases and partnerships. | |
| starlightthera.com | 2023 | Plano, United States | – | – | Develops AI-driven drugs for brain and CNS cancers through research and clinical trials. |
Detailed competitors of RegenMed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RegenMed
The website of RegenMed (rgnmed.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 49.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as RegenMed (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RegenMed
RegenMed was founded in 2014 and raised its 1st funding round 11 years after it was founded.
RegenMed is headquartered in Greenwich, United States. It is registered at Greenwich, Connecticut, United States.
Michael Tierney is the current CEO of RegenMed. They have also founded this company.
RegenMed is a funded company, having raised a total of $290K across 1 funding round to date. The company's 1st funding round was a Seed of $290K, raised on Feb 2025.
RegenMed was founded in 2014 in Greenwich, United States, as a healthcare technology firm specializing in translational regenerative medicine. A platform has been developed for collecting and analyzing real-world evidence to support medical research. Operations serve a global client base in the healthcare data sector, with services focused on clinical and financial outcomes for clinicians. Partnerships with leading healthcare organizations have been established, alongside backing from investors.
RegenMed's top competitors include Fauna Bio, Predxbio and BeaconCure.
RegenMed offers inCytesâ„¢, Benchmarcâ„¢, and Circles.
RegenMed operates through Regenmed, Inc..